Ziyad Al-Aly, MD @zalaly · 04 May 2026
We used VA data to emulate a target trial. 588,168 adults with type 2 diabetes: ▸139,546 started a GLP-1 drug ▸ 448,622 started an SGLT2 inhibitor ▸ Followed for up to 3 years
3 516Views
11Likes
0Reposts
3Replies
0Quotes
0Bookmarks
Is that a lot?
2.41×vs 10K–100K median1 456 views is typical
11.05%Reachviews ÷ followers
0.40%Engagement rateof viewers reacted